go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

North Dakota rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $3,467 · 10th–90th $2,692$3,4670%50%10th$3,467Professionalmedian $3,467 · 10th–90th $2,512$4,0740%20%10th90th$3,467$2.0K$5.0K$10.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,691.53
Median
$3,467.37
Typical High
$3,467.37
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,511.89
Median
$3,467.37
Typical High
$3,630.78
BCBS
Setting
Professional
Modifier
Global
Typical Low
$2,754.23
Median
$3,715.35
Typical High
$3,715.35
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$6,025.60
Medica
Setting
Facility
Modifier
Global
Typical Low
$2,089.30
Median
$4,570.88
Typical High
$6,025.60
Medica
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$23,988.33
United
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$5,495.41